$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
The difference between avatrombopag/Sukesin and Qing'anxin
2026-02-01 22:25:32
Check Details
Effects and prices of the Laotian version of Avatrombopag/Suxin
2026-02-01 22:25:32
Check Details
Spasentan/Sparsentan 2024 price and where to buy it
2026-02-01 22:25:32
Check Details
Spasentan/sparsentan mechanism of action
2026-02-01 22:25:32
Check Details
What kind of nephritis does sparsentan/sparsentan treat?
2026-02-01 22:25:32
Check Details
Detailed explanation of the efficacy and role of bedaquiline
2026-02-01 22:25:32
Check Details
Can drug-resistant tuberculosis be treated without bedaquiline?
2026-02-01 22:25:32
Check Details
Ribociclib: a new treatment option and its potential advantages
2026-02-01 22:25:32
Check Details
Tumors disappear after taking crizotinib in advanced lung cancer
2026-02-01 22:25:32
Check Details
What are the side effects of venetoclax?
2026-02-01 22:25:32
Check Details
Patient Medication Instructions for Aceminid
2026-02-01 22:25:32
Check Details
Which country is Asimini developed and produced in?
2026-02-01 22:25:32
Check Details
1
2
...
1073
1074
1075
1076
1077
1078
1079
...
10223
10224
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Axitinib: Indications, Mechanism of Action & Key Safety Warnings
2
Cabergoline Explained: Mechanism, Four Key Warnings & Dosing Guide
3
Capmatinib Generic Guide: Laos Version Availability, Efficacy & Safety Overview
4
Eltrombopag Administration Timing and Alternative Therapy Guide
5
Osimertinib Safety Guide: Foods to Avoid, Mechanism of Action, and Pre-Treatment Warnings
6
Avatrombopag: A Complete Guide to Dosage, Mechanism, and Clinical Use
7
Tazemetostat Dosage Guide: Laos Generic vs. Original Tazverik Comparison
8
Tivozanib: A Next-Generation Highly Selective VEGFR-Targeted Therapy Explained
9
Capmatinib Clinical Guide: Drug Comparisons, Treatment Strategies, and Combination Therapy Prospects
10
Avatrombopag Complete Guide: Efficacy, Indications, and TPO-RA Drug Comparisons
11
Pralsetinib Clinical Guide: Discontinuation Principles, Drug Comparisons, and Treatment Strategies
12
Venetoclax Clinical Guide: Mechanism, Indications, and Originator vs. Generic Comparison